Fighting cancer by triggering non-canonical mitochondrial permeability transition-driven necrosis through reactive
Qingwen Xiao1, Bingling Zhong1, Ying Hou1
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao.
Abstract:
Non-apoptotic necrosis shows therapeutic potential for the treatment of various diseases, especially cancer. Mitochondrial permeability transition (MPT)-driven necrosis is a form of non-apoptotic cell death triggered by oxidative stress and cytosolic Ca2+ overload, and relies on cyclophilin D (CypD). Previous reports demonstrated that isobavachalcone (IBC), a natural chalcone, has anticancer effect by apoptosis induction. Here, we found that IBC induced regulated necrosis in cancer cells. IBC triggered non-apoptotic cell death in lung and breast cancer cells mediated by reactive oxygen species (ROS). IBC caused mitochondrial injury and dysfunction as evidenced by mitochondrial Ca2+ overload, the opening of MPT pore, mitochondrial membrane potential collapse, and structural damages. IBC-triggered cell death could be remarkably reversed by the ROS scavengers, cyclosporin A (CsA) and hemin, whereas CypD silence and heme oxygenase-1 overexpression failed to do so. Protein kinase B, dihydroorotate dehydrogenase, and mitogen-activated protein kinases were not involved in IBC-induced necrosis as well. In addition, IBC showed an anticancer effect in a 4T1 breast cancer cell-derived allograft mouse model, and this effect was considerably reversed by CsA. Collectively, our results showed that IBC triggered non-canonical MPT-driven necrosis mediated by ROS in cancer cells, which might provide a novel strategy for fighting against cancer.
Insights
Isoba vachalcone (IBC) induces non-apoptotic necrosis in cancer cells by triggering mitochondrial permeability transition (MPT) via reactive oxygen species (ROS). This cell death pathway, independent of cyclophilin D (CypD), offers a novel anticancer strategy.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Non-apoptotic necrosis presents therapeutic potential, particularly in cancer treatment.
- Mitochondrial permeability transition (MPT)-driven necrosis is a critical form of programmed cell death.
- Isoba vachalcone (IBC), a natural chalcone, is known for inducing apoptosis in cancer cells.
Purpose of the Study:
- To investigate the mechanism of IBC-induced cell death in cancer.
- To determine if IBC induces non-apoptotic necrosis.
- To explore the role of reactive oxygen species (ROS) and MPT in IBC-mediated cell death.
Main Methods:
- Treatment of lung and breast cancer cells with IBC.
- Assessment of cell death pathways (apoptosis vs. necrosis).
- Measurement of mitochondrial function, ROS production, and MPT pore opening.
- Involvement of cyclophilin D (CypD) and ROS scavengers (cyclosporin A, hemin) were tested.
- Evaluation of IBC's efficacy in a 4T1 breast cancer allograft mouse model.
Main Results:
- IBC induced non-apoptotic, ROS-mediated necrosis in cancer cells.
- IBC triggered mitochondrial injury, including Ca2+ overload, MPT pore opening, and membrane potential collapse.
- ROS scavengers, but not CypD manipulation, reversed IBC-induced cell death.
- IBC demonstrated anticancer effects in vivo, which were partially reversed by cyclosporin A.
Conclusions:
- IBC induces non-canonical MPT-driven necrosis via ROS in cancer cells.
- This mechanism offers a novel therapeutic strategy for cancer treatment.
- Targeting ROS-mediated necrosis presents a promising avenue for anticancer drug development.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
The Intrinsic Apoptotic Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...


